Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04920968 |
| Title | Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 OVERALL (PALG ALL7) |
| Acronym | PALG ALL7 |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Maria Sklodowska-Curie National Research Institute of Oncology |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | POL |